SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cost-Effectiveness of Interventions for the Prevention and Control of COVID-19: A Systematic Review and Meta-Analysis
16 references·0 citing·41 second hop
Cost-Effectiveness of Interventions for the Prevention and Control of COVID-19: A Systematic Review and Meta-Analysis (2021)Cost-Effectiveness of Interventions for t…Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States (2022)Cost-effectiveness analysis o…The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization (2021)The potential public health a…Potential health and economic impacts of dexamethasone treatment for patients with COVID-19 (2021)Potential health and economic…Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis (2021)Economic value of vaccines to…Economic evaluation for mass vaccination against COVID-19 (2021)Economic evaluation for mass …Cost‐effectiveness of intensive care for hospitalized COVID-19 patients: experience from South Africa (2021)Cost‐effectiveness of intensi…A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States (2021)A Cost-Effectiveness Framewor…The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States (2020)The Potential Health Care Cos…The Benefits and Costs of Using Social Distancing to Flatten the Curve for COVID-19 (2020)The Benefits and Costs of Usi…Economic evaluation of programs against COVID-19: A systematic review (2020)Economic evaluation of progra…“Stay at Home, Protect the National Health Service, Save Lives”: A cost benefit analysis of the lockdown in the United Kingdom (2020)“Stay at Home, Protect the Na…Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation (2015)Preferred reporting items for…Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies (2014)Comparative efficiency resear…Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Consolidated Health Economic …Net Health Benefits (1998)Net Health BenefitsMeta-analysis in clinical trials (1986)Meta-analysis in clinical tri…Costs, Risks, and Benefits of Surgery. (1978)Statistical Methods for Meta-Analysis. (1986)Book Reviews: Statistical Methods for Meta-Analysis Larry V. Hedges and Ingram Olkin New York: Academic Press, 1985. xxii + 369 pp (1988)Quantifying heterogeneity in a meta‐analysis (2002)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal (2024)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement (2016)Measuring inconsistency in meta-analyses (2003)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey (2020)Psychological Impact of COVID-19 and Lockdown among University Students in Malaysia: Implications and Policy Recommendations (2020)The COVID-19 Pandemic through the Lens of Education in the Philippines: The New Normal (2020)The Global Macroeconomic Impacts of COVID-19: Seven Scenarios (2020)Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62) (2002)Labor Markets During the COVID-19 Crisis: A Preliminary View (2020)Loneliness: A signature mental health concern in the era of COVID-19 (2020)Risk factors for self-harm repetition in adolescents: A systematic review (2021)Mental Health and Wellbeing in Young People in the UK during Lockdown (COVID-19) (2022)Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)Defining Elements of Value in Health Care—A Health Economics Approach: An ISPOR Special Task Force Report [3] (2018)La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19 (2020)Economic evaluation of COVID-19 vaccination: A systematic review (2023)Increasing risk II: Its economic consequences (1971)The Analytics of Uncertainty and Information (1992)The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies (1999)Representing uncertainty: the role of cost‐effectiveness acceptability curves (2001)American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options (2015)Explaining the role of the social determinants of health on health inequality in South Africa (2015)The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)Impact of conditional and unconditional cash transfers on health outcomes and use of health services in humanitarian settings: a mixed-methods systematic review (2022)Impact of health system governance on healthcare quality in low-income and middle-income countries: a scoping review (2023)US Valuation of the EQ-5D Health States (2005)Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses (2016)COVID-19 and African Americans (2020)The economic burden of coronavirus disease 2019 (COVID-19): evidence from Iran (2021)Economic Burden of COVID-19: A Systematic Review (2022)
this work references cited by second hop

References

  • 1986Meta-analysis in clinical trials39,515 cited
  • 2015Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation13,139 cited
  • 2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force2,025 cited
  • 1998Net Health Benefits1,104 cited
  • 2020The Benefits and Costs of Using Social Distancing to Flatten the Curve for COVID-19439 cited
  • 2020The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States377 cited
  • 2021The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization139 cited
  • 2021Cost‐effectiveness of intensive care for hospitalized COVID-19 patients: experience from South Africa135 cited
  • 2020“Stay at Home, Protect the National Health Service, Save Lives”: A cost benefit analysis of the lockdown in the United Kingdom102 cited
  • 2021Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysis77 cited
  • 2021Potential health and economic impacts of dexamethasone treatment for patients with COVID-1976 cited
  • 2020Economic evaluation of programs against COVID-19: A systematic review73 cited
  • 2014Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

68 cited
  • 2021A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States61 cited
  • 2022Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States61 cited
  • 2021Economic evaluation for mass vaccination against COVID-1956 cited
  • Cited by

    No citing works inside the corpus for this window.